Spots Global Cancer Trial Database for metastatic lung cancer
Every month we try and update this database with for metastatic lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Piloting Pathways With Lung Cancer Patients | NCT04161157 | Metastatic Lung... | Pathways | 18 Years - | University of Kentucky | |
| The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel | NCT01814150 | Metastatic Lung... Metastatic Brea... Metastatic Gast... Metastatic Pros... Metastatic Blad... | 18 Years - | Meir Medical Center | ||
| A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) | NCT04222972 | RET-fusion Non ... Lung Neoplasm Carcinoma, Non-... Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Disea... Head and Neck N... Adenocarcinoma Carcinoma Neoplasms by Hi... Neoplasms, Germ... Neoplasms, Nerv... | Pralsetinib Carboplatin Cisplatin Pemetrexed Pembrolizumab Gemcitabine Paclitaxel Nab-Paclitaxel | 18 Years - | Hoffmann-La Roche | |
| Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | NCT00373204 | Lung Cancer | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Safety and Efficacy of Cryoablation for Metastatic Lung Tumors | NCT01307501 | Metastatic Lung... | Cryoablation | 18 Years - | Boston Scientific Corporation | |
| Vapor Ablation for Localized Cancer Lesions | NCT03514329 | Non Small Cell ... Metastatic Lung... Lung Cancer | Bronchoscopic T... | 18 Years - | Uptake Medical Technology, Inc. | |
| Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer | NCT04614103 | Metastatic Non ... | LN-145 LN-145 | 18 Years - 70 Years | Iovance Biotherapeutics, Inc. | |
| Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners | NCT02596490 | Lung Cancer | Questionnaires Meditation and ... Cancer-Related ... | 18 Years - | M.D. Anderson Cancer Center | |
| Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | NCT00373204 | Lung Cancer | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer | NCT00365183 | Non-Small Cell ... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Trial of Motexafin Gadolinium and Pemetrexed (Alimta®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer | NCT00365183 | Non-Small Cell ... | Motexafin gadol... | 18 Years - | Pharmacyclics LLC. | |
| Non-invasive Measurement of PD-L1 Levels With Positron Emission Tomography (PET) in Head and Neck Malignancies and Intracranial Metastases | NCT05408871 | Cancer Head Nec... Metastatic Canc... Metastatic Lung... | adnectin 18F-BM... adnectin 18F-BM... | 18 Years - | Yale University | |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously | NCT01543672 | Lung Cancer Metastatic Lung... | Stereotactic Bo... Stereotactic Bo... | 18 Years - | The Netherlands Cancer Institute | |
| High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer | NCT03007875 | Non-small Cell ... | high-activity n... | 30 Years - 60 Years | Fuda Cancer Hospital, Guangzhou | |
| Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours | NCT00351962 | Lung Neoplasms Lung Cancer | Fractionated St... | 18 Years - | AHS Cancer Control Alberta | |
| A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer | NCT05361174 | Unresectable Me... Metastatic Mela... Stage III Non-s... Stage IV Non-sm... | IOV-4001 | 18 Years - | Iovance Biotherapeutics, Inc. | |
| Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners | NCT02596490 | Lung Cancer | Questionnaires Meditation and ... Cancer-Related ... | 18 Years - | M.D. Anderson Cancer Center | |
| Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC | NCT03044626 | Carcinoma，Non-S... Metastatic Lung... Nonsmall Cell L... Lung Adenocarci... Large Cell Lung... | Radiotherapy Nivolumab | 18 Years - | AIO-Studien-gGmbH | |
| Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer | NCT02250326 | Carcinoma, Non-... | nab-paclitaxel ... CC-486 Duravalumab | 18 Years - | Celgene | |
| McMaster Catheterization for Thoracoscopic Surgery Study | NCT02640326 | Non-Small Cell ... Lung Neoplasms Metastatic Lung... Urinary Retenti... Urinary Tract I... | No Foley Urinar... Standard of car... | 18 Years - | McMaster University | |
| Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy | NCT00858364 | Non-Small Cell ... Anemia Cancer Lung Cancer | Darbepoetin alf... Placebo | 18 Years - | Amgen | |
| Immune Response Under Immunotherapy in Metastatic NSCLC: Sputum, Blood Samples and Microbioata Study | NCT04804137 | Non-squamous Lu... Metastatic Lung... | Blood sputum saliva stool | 18 Years - | University Hospital, Tours | |
| Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease | NCT02469701 | Non-small Cell ... Lung Cancer Metastatic Lung... NSCLC | nivolumab and a... | 18 Years - | Brown University | |
| A Study of Motexafin Gadolinium (MGd) in Combination With Docetaxel and Cisplatin for Treatment of Non-Small Cell Lung Cancer (NSCLC) | NCT00102505 | Non-Small-Cell ... Carcinoma, Bron... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Piloting Pathways With Lung Cancer Patients | NCT04161157 | Metastatic Lung... | Pathways | 18 Years - | University of Kentucky | |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | NCT03329950 | Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt... | CDX-1140 CDX-301 pembrolizumab Chemotherapy | 18 Years - | Celldex Therapeutics | |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals | |
| Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors | NCT05544240 | Metastatic Canc... Metastatic Brea... Metastatic Lung... Solid Tumor Cancer | SV-101 | 18 Years - | Williams Cancer Foundation | |
| MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer | NCT00799240 | Non Small Cell ... | Arm A: Pemetrex... Arm B Pemetrexe... | 18 Years - | University of Kansas Medical Center | |
| GRN1005 for Brain Metastases From Breast or Lung Cancer | NCT01679743 | Breast Cancer Lung Neoplasms Breast Neoplasm... Lung Cancer | Trastuzumab GRN 1005 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria | NCT04708483 | Cancer, Lung Perfusion Compu... Cancer Liver Metastatic Lung... Metastatic Live... | Extra DCE-CT sc... | 18 Years - | Hyperfusion | |
| Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors | NCT05544240 | Metastatic Canc... Metastatic Brea... Metastatic Lung... Solid Tumor Cancer | SV-101 | 18 Years - | Williams Cancer Foundation | |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously | NCT01543672 | Lung Cancer Metastatic Lung... | Stereotactic Bo... Stereotactic Bo... | 18 Years - | The Netherlands Cancer Institute | |
| MK-0646 Insulin Growth Factor 1 Receptor Antibody in Stage IIIb or IV Metastatic Non-Squamous Lung Cancer | NCT00799240 | Non Small Cell ... | Arm A: Pemetrex... Arm B Pemetrexe... | 18 Years - | University of Kansas Medical Center | |
| Pirfenidone Combined With Standard First-Line Chemotherapy in Advanced-Stage Lung NSCLC | NCT03177291 | Lung Cancer Non Small Cell ... Advanced Cancer Metastatic Lung... Squamous Cell L... Non-Squamous No... | Pirfenidone Carboplatin Paclitaxel Pemetrexed | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Definitive Radiation for High-Risk Spine Metastases | NCT06165419 | Metastatic Canc... Metastatic Lung... Metastatic Brea... Metastatic Tumo... Metastatic Tumo... Metastatic Tumo... Spine Metastase... Metastasis | SBRT to the spi... | 18 Years - | Stony Brook University | |
| Emulation of the KEYNOTE-189 Trial Using Electronic Health Records | NCT05908799 | Non-small Cell ... Metastatic Lung... | Pembrolizumab +... Pemetrexed-Plat... | - | Aetion, Inc. | |
| Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases | NCT03143322 | Metastatic Brea... Metastatic Lung... Metastatic Pros... Bone Metastases | SBRT | 18 Years - 75 Years | UNICANCER | |
| Vapor Ablation for Localized Cancer Lesions | NCT03514329 | Non Small Cell ... Metastatic Lung... Lung Cancer | Bronchoscopic T... | 18 Years - | Uptake Medical Technology, Inc. | |
| Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients | NCT06032052 | Elderly Patient... Metastatic Lung... | Single drug che... | 65 Years - | Hubei Cancer Hospital | |
| Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors | NCT03037385 | RET-altered Non... Medullary Thyro... RET-altered Pap... RET-altered Col... RET-altered Sol... Lung Neoplasm Carcinoma, Non-... Thyroid Disease... Thyroid Neoplas... Thyroid Cancer,... Carcinoma, Neur... Respiratory Tra... Thoracic Neopla... Neoplasms by Si... Neoplasms Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Endocrine Syste... Endocrine Gland... Head and Neck N... Adenocarcinoma,... Adenocarcinoma Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neuroendocrine ... Neuroectodermal... Neoplasms, Germ... Neoplasms, Nerv... Colonic Neoplas... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... | pralsetinib (BL... | 18 Years - | Hoffmann-La Roche | |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously | NCT01543672 | Lung Cancer Metastatic Lung... | Stereotactic Bo... Stereotactic Bo... | 18 Years - | The Netherlands Cancer Institute | |
| Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable NSCLC or Metastatic Lung Tumours | NCT00351962 | Lung Neoplasms Lung Cancer | Fractionated St... | 18 Years - | AHS Cancer Control Alberta | |
| Vapor Ablation for Localized Cancer Lesions of the Lung (VAPORIZE) | NCT03198468 | Non Small Cell ... Metastatic Lung... Lung Cancer | Bronchoscopic T... | 18 Years - | Uptake Medical Technology, Inc. | |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | NCT03329950 | Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt... | CDX-1140 CDX-301 pembrolizumab Chemotherapy | 18 Years - | Celldex Therapeutics | |
| Safety and Efficacy of Cryoablation for Metastatic Lung Tumors | NCT01307501 | Metastatic Lung... | Cryoablation | 18 Years - | Boston Scientific Corporation | |
| Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer | NCT05502913 | Metastatic Lung... | Antibiotics FMT (Fecal Micr... | 18 Years - | Soroka University Medical Center | |
| Datopotamab (DS-1062a) in Advanced and/or Unresectable Non-Small Cell Lung Cancer | NCT04940325 | Metastatic Lung... | DS-1062a | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| A Study to Evaluate the Impact of Liquid Biopsy in Participants With a Clinical Diagnosis of Advanced Cancer | NCT05846594 | Metastatic Lung... Metastatic Gast... | FoundationOne® ... Standard of Car... | 18 Years - | Hoffmann-La Roche | |
| (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations | NCT05241873 | Lung Neoplasm M... Carcinoma, Non-... Respiratory Tra... Neoplasms Neoplasms by Si... Lung Diseases Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Adenocarcinoma Carcinoma Neoplasms by Hi... EGFR Exon 20 Mu... EGFR Exon 20 In... EGFR Activating... Antineoplastic ... Metastatic Lung... Brain Metastase... EGFR-mutated NS... EGFR Atypical M... | BLU-451 Carboplatin Pemetrexed | 18 Years - | Blueprint Medicines Corporation | |
| Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer | NCT06343402 | Non-small Cell ... Metastatic Non-... NSCLC KRAS G12C Metastatic Lung... Advanced Lung C... | BBO-8520 Pembrolizumab | 18 Years - | TheRas, Inc., d/b/a BridgeBio Oncology Therapeutics | |
| The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel | NCT01814150 | Metastatic Lung... Metastatic Brea... Metastatic Gast... Metastatic Pros... Metastatic Blad... | 18 Years - | Meir Medical Center | ||
| Evaluation of the Feasibility and Clinical Relevance of Liquid Biopsy in Patients With Suspicious Metastatic Lung Cancer | NCT03721120 | Metastatic Lung... | InvisionFirst® ... | 18 Years - | Centre Leon Berard | |
| Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer | NCT05502913 | Metastatic Lung... | Antibiotics FMT (Fecal Micr... | 18 Years - | Soroka University Medical Center | |
| The Impact of Radiotherapy on Oligometastatic Cancer | NCT05933876 | Metastasis Metastatic Brea... Metastatic Pros... Metastatic Colo... Metastatic Lung... | To propose a di... To propose a di... To propose a di... | 18 Years - | Institut Investigacio Sanitaria Pere Virgili | |
| GRN1005 for Brain Metastases From Breast or Lung Cancer | NCT01679743 | Breast Cancer Lung Neoplasms Breast Neoplasm... Lung Cancer | Trastuzumab GRN 1005 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| Advanced Non-Small Cell Lung Cancer Progressing After at Least One Prior Therapy For Metastatic Disease | NCT02469701 | Non-small Cell ... Lung Cancer Metastatic Lung... NSCLC | nivolumab and a... | 18 Years - | Brown University | |
| Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases | NCT03143322 | Metastatic Brea... Metastatic Lung... Metastatic Pros... Bone Metastases | SBRT | 18 Years - 75 Years | UNICANCER | |
| CALM: Managing Distress in Malignant Brain Cancer | NCT06180460 | Brain Tumor Brain Metastase... Brain Cancer Metastatic Lung... Metastatic Brea... Metastatic Mela... Metastatic Colo... Metastatic Kidn... | CALM Treatment as us... | 18 Years - | Virginia Commonwealth University | |
| Safety and Efficacy of Cryoablation for Metastatic Lung Tumors | NCT01307501 | Metastatic Lung... | Cryoablation | 18 Years - | Boston Scientific Corporation | |
| Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers | NCT03073473 | Pancreatic Canc... Metastatic Brea... Metastatic Lung... Metastatic Colo... Metastatic Mela... Metastatic Pros... | NantHealth GPS ... | 18 Years - | Cota Inc. | |
| A Study to Assess PV-10 Chemoablation of Cancer of the Liver | NCT00986661 | Cancer Metastat... Hepatocellular ... Metastatic Mela... Metastatic Ocul... Metastatic Uvea... Metastatic Lung... Metastatic Colo... Metastatic Colo... Metastatic Brea... Metastatic Panc... | PV-10 (10% rose... | 18 Years - | Provectus Pharmaceuticals | |
| A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors | NCT05143970 | Metastatic Canc... Metastatic Brea... Metastatic Panc... Metastatic Gast... Metastatic Lung... Metastatic Ovar... Oesophageal Can... Endometrial Can... Advanced Solid ... | IPH5301 ALONE O... | 18 Years - | Institut Paoli-Calmettes | |
| Immunotherapy With or Without SBRT in Patients With Stage IV Non-small Cell Lung Cancer | NCT03867175 | Metastatic Lung... Stage IV Lung C... | Stereotactic Bo... Pembrolizumab | 18 Years - | Wake Forest University Health Sciences | |
| Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy | NCT00858364 | Non-Small Cell ... Anemia Cancer Lung Cancer | Darbepoetin alf... Placebo | 18 Years - | Amgen | |
| Vapor Ablation for Localized Cancer Lesions | NCT03514329 | Non Small Cell ... Metastatic Lung... Lung Cancer | Bronchoscopic T... | 18 Years - | Uptake Medical Technology, Inc. | |
| DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria | NCT04708483 | Cancer, Lung Perfusion Compu... Cancer Liver Metastatic Lung... Metastatic Live... | Extra DCE-CT sc... | 18 Years - | Hyperfusion | |
| Phase 1 Trial of SYNC-T - Immunotherapy for Patients With Advanced/Metastatic Solid Tumors | NCT05544240 | Metastatic Canc... Metastatic Brea... Metastatic Lung... Solid Tumor Cancer | SV-101 | 18 Years - | Williams Cancer Foundation | |
| Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) | NCT00373204 | Lung Cancer | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| High-activity Natural Killer Immunotherapy for Small Metastases of Non-small Cell Lung Cancer | NCT03007875 | Non-small Cell ... | high-activity n... | 30 Years - 60 Years | Fuda Cancer Hospital, Guangzhou | |
| Safety and Efficacy of OBX-115 in Advanced Solid Tumors | NCT06060613 | Tumor Skin Metastatic Mela... Melanoma Lung Cancer Metastatic Lung... Non Small Cell ... Metastatic Non ... | OBX-115 | 18 Years - | Obsidian Therapeutics, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
